Investing.com UK - Financial Markets Worldwide
Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Merck sees up to 4.8 percent gain in 2015 adjusted EBITDA on weak euro

Published 19/05/2015, 06:26
Merck sees up to 4.8 percent gain in 2015 adjusted EBITDA on weak euro
MRCG
-
SIAL
-

FRANKFURT (Reuters) - Merck KGaA (DE:MRCG) said 2015 adjusted core earnings would rise to 3.45-3.55 billion euros (2-3 billion pounds) in 2015, helped by a strong U.S. dollar boosting the value of overseas sales and the recent takeover of high-tech chemicals maker AZ Electronic Materials.

The forecast, which does not include the planned $17 billion acquisition of Sigma-Aldrich Corp (O:SIAL), implies an increase in adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) of between 1.8 and 4.8 percent.

Merck, which makes drugs, high-tech chemicals and laboratory supplies, said on Tuesday its first-quarter adjusted EBITDA rose 5.7 percent to 853 million euros, slightly below the 862 million euros expected on average by analysts.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.